25-hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease.
Identifieur interne : 000F85 ( PubMed/Checkpoint ); précédent : 000F84; suivant : 000F8625-hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease.
Auteurs : Masahiko Suzuki [Japon] ; Masayuki Yoshioka ; Masaya Hashimoto ; Maiko Murakami ; Keiichi Kawasaki ; Miki Noya ; Daisuke Takahashi ; Mitsuyoshi UrashimaSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2012.
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Cohort Studies, Cross-Sectional Studies, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Parkinson Disease (blood), Parkinson Disease (genetics), Polymorphism, Genetic, Receptors, Calcitriol (genetics), Severity of Illness Index, Vitamin D (analogs & derivatives), Vitamin D (blood), Vitamin D (genetics).
- MESH :
- chemical , analogs & derivatives : Vitamin D.
- chemical , blood : Vitamin D.
- chemical , genetics : Receptors, Calcitriol, Vitamin D.
- blood : Parkinson Disease.
- genetics : Parkinson Disease.
- Aged, Aged, 80 and over, Cohort Studies, Cross-Sectional Studies, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Polymorphism, Genetic, Severity of Illness Index.
Abstract
We aimed to examine associations among serum 25-hydroxyvitamin D levels, 1,25-dihyroxyvitamin D levels, vitamin D receptor polymorphisms, vitamin D binding protein gene polymorphisms, and the severity of Parkinson's disease. In 137 patients, the severity of Parkinson's disease was evaluated using Hoehn & Yahr stage and Unified Parkinson's Disease Rating Stage by neurologists and compared with 25-hydroxyvitamin D, 1,25-hydroxyvitamin D, vitamin D receptor polymorphisms, ie, FokI (rs10735810), BsmI (rs1544410), Cdx2 (rs11568820), ApaI (rs7976091), and TaqI (rs731236), and vitamin D binding protein gene polymorphisms GC1 (rs7041)/GC2 (rs4588) in a cross-sectional study. Mean ± standard deviation levels of 25-hydroxyvitamin D were 21.1 ± 9.0 ng/mL. Levels were deficient (<20 ng/mL) in 49% of patients. In contrast, 1,25-hydroxyvitamin D levels were considered normal in all patients. Higher circulating 25-hydroxyvitamin D levels were significantly associated with milder Parkinson's disease evaluated by Hoehn & Yahr stage (P = .002) and total Unified Parkinson's Disease Rating Stage (P = .004) even after multivariate adjustment for 8 covariates, including disease duration. However, significant associations were not observed in 1,25-hydroxyvitamin D levels. Under multivariate analysis with 25-hydroxyvitamin D as well as other 8 covariates including disease duration, carriers of vitamin D receptor FokICC genotype had a milder form of Parkinson's disease: odds ratio, 0.32; 95% confidence interval, 0.16 to 0.66, P = 0.002. These results suggest that higher 25-hydroxyvitamin D levels and the vitamin D receptor FokICC genotype may be independently associated with milder forms of Parkinson's disease. However, significant associations were not observed in 1,25-hydroxyvitamin D levels.
DOI: 10.1002/mds.24016
PubMed: 22213340
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:22213340Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">25-hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease.</title>
<author><name sortKey="Suzuki, Masahiko" sort="Suzuki, Masahiko" uniqKey="Suzuki M" first="Masahiko" last="Suzuki">Masahiko Suzuki</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Neurology, Jikei University School of Medicine, Tokyo, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Neurology, Jikei University School of Medicine, Tokyo</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Yoshioka, Masayuki" sort="Yoshioka, Masayuki" uniqKey="Yoshioka M" first="Masayuki" last="Yoshioka">Masayuki Yoshioka</name>
</author>
<author><name sortKey="Hashimoto, Masaya" sort="Hashimoto, Masaya" uniqKey="Hashimoto M" first="Masaya" last="Hashimoto">Masaya Hashimoto</name>
</author>
<author><name sortKey="Murakami, Maiko" sort="Murakami, Maiko" uniqKey="Murakami M" first="Maiko" last="Murakami">Maiko Murakami</name>
</author>
<author><name sortKey="Kawasaki, Keiichi" sort="Kawasaki, Keiichi" uniqKey="Kawasaki K" first="Keiichi" last="Kawasaki">Keiichi Kawasaki</name>
</author>
<author><name sortKey="Noya, Miki" sort="Noya, Miki" uniqKey="Noya M" first="Miki" last="Noya">Miki Noya</name>
</author>
<author><name sortKey="Takahashi, Daisuke" sort="Takahashi, Daisuke" uniqKey="Takahashi D" first="Daisuke" last="Takahashi">Daisuke Takahashi</name>
</author>
<author><name sortKey="Urashima, Mitsuyoshi" sort="Urashima, Mitsuyoshi" uniqKey="Urashima M" first="Mitsuyoshi" last="Urashima">Mitsuyoshi Urashima</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="doi">10.1002/mds.24016</idno>
<idno type="RBID">pubmed:22213340</idno>
<idno type="pmid">22213340</idno>
<idno type="wicri:Area/PubMed/Corpus">000F11</idno>
<idno type="wicri:Area/PubMed/Curation">000F11</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000F85</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">25-hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease.</title>
<author><name sortKey="Suzuki, Masahiko" sort="Suzuki, Masahiko" uniqKey="Suzuki M" first="Masahiko" last="Suzuki">Masahiko Suzuki</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Neurology, Jikei University School of Medicine, Tokyo, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Neurology, Jikei University School of Medicine, Tokyo</wicri:regionArea>
<placeName><settlement type="city">Tokyo</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Yoshioka, Masayuki" sort="Yoshioka, Masayuki" uniqKey="Yoshioka M" first="Masayuki" last="Yoshioka">Masayuki Yoshioka</name>
</author>
<author><name sortKey="Hashimoto, Masaya" sort="Hashimoto, Masaya" uniqKey="Hashimoto M" first="Masaya" last="Hashimoto">Masaya Hashimoto</name>
</author>
<author><name sortKey="Murakami, Maiko" sort="Murakami, Maiko" uniqKey="Murakami M" first="Maiko" last="Murakami">Maiko Murakami</name>
</author>
<author><name sortKey="Kawasaki, Keiichi" sort="Kawasaki, Keiichi" uniqKey="Kawasaki K" first="Keiichi" last="Kawasaki">Keiichi Kawasaki</name>
</author>
<author><name sortKey="Noya, Miki" sort="Noya, Miki" uniqKey="Noya M" first="Miki" last="Noya">Miki Noya</name>
</author>
<author><name sortKey="Takahashi, Daisuke" sort="Takahashi, Daisuke" uniqKey="Takahashi D" first="Daisuke" last="Takahashi">Daisuke Takahashi</name>
</author>
<author><name sortKey="Urashima, Mitsuyoshi" sort="Urashima, Mitsuyoshi" uniqKey="Urashima M" first="Mitsuyoshi" last="Urashima">Mitsuyoshi Urashima</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Cohort Studies</term>
<term>Cross-Sectional Studies</term>
<term>Female</term>
<term>Genetic Predisposition to Disease</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease (blood)</term>
<term>Parkinson Disease (genetics)</term>
<term>Polymorphism, Genetic</term>
<term>Receptors, Calcitriol (genetics)</term>
<term>Severity of Illness Index</term>
<term>Vitamin D (analogs & derivatives)</term>
<term>Vitamin D (blood)</term>
<term>Vitamin D (genetics)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Vitamin D</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Vitamin D</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Receptors, Calcitriol</term>
<term>Vitamin D</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Cohort Studies</term>
<term>Cross-Sectional Studies</term>
<term>Female</term>
<term>Genetic Predisposition to Disease</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Polymorphism, Genetic</term>
<term>Severity of Illness Index</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We aimed to examine associations among serum 25-hydroxyvitamin D levels, 1,25-dihyroxyvitamin D levels, vitamin D receptor polymorphisms, vitamin D binding protein gene polymorphisms, and the severity of Parkinson's disease. In 137 patients, the severity of Parkinson's disease was evaluated using Hoehn & Yahr stage and Unified Parkinson's Disease Rating Stage by neurologists and compared with 25-hydroxyvitamin D, 1,25-hydroxyvitamin D, vitamin D receptor polymorphisms, ie, FokI (rs10735810), BsmI (rs1544410), Cdx2 (rs11568820), ApaI (rs7976091), and TaqI (rs731236), and vitamin D binding protein gene polymorphisms GC1 (rs7041)/GC2 (rs4588) in a cross-sectional study. Mean ± standard deviation levels of 25-hydroxyvitamin D were 21.1 ± 9.0 ng/mL. Levels were deficient (<20 ng/mL) in 49% of patients. In contrast, 1,25-hydroxyvitamin D levels were considered normal in all patients. Higher circulating 25-hydroxyvitamin D levels were significantly associated with milder Parkinson's disease evaluated by Hoehn & Yahr stage (P = .002) and total Unified Parkinson's Disease Rating Stage (P = .004) even after multivariate adjustment for 8 covariates, including disease duration. However, significant associations were not observed in 1,25-hydroxyvitamin D levels. Under multivariate analysis with 25-hydroxyvitamin D as well as other 8 covariates including disease duration, carriers of vitamin D receptor FokICC genotype had a milder form of Parkinson's disease: odds ratio, 0.32; 95% confidence interval, 0.16 to 0.66, P = 0.002. These results suggest that higher 25-hydroxyvitamin D levels and the vitamin D receptor FokICC genotype may be independently associated with milder forms of Parkinson's disease. However, significant associations were not observed in 1,25-hydroxyvitamin D levels.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">22213340</PMID>
<DateCreated><Year>2012</Year>
<Month>02</Month>
<Day>13</Day>
</DateCreated>
<DateCompleted><Year>2012</Year>
<Month>06</Month>
<Day>14</Day>
</DateCompleted>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>27</Volume>
<Issue>2</Issue>
<PubDate><Year>2012</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>25-hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease.</ArticleTitle>
<Pagination><MedlinePgn>264-71</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.24016</ELocationID>
<Abstract><AbstractText>We aimed to examine associations among serum 25-hydroxyvitamin D levels, 1,25-dihyroxyvitamin D levels, vitamin D receptor polymorphisms, vitamin D binding protein gene polymorphisms, and the severity of Parkinson's disease. In 137 patients, the severity of Parkinson's disease was evaluated using Hoehn & Yahr stage and Unified Parkinson's Disease Rating Stage by neurologists and compared with 25-hydroxyvitamin D, 1,25-hydroxyvitamin D, vitamin D receptor polymorphisms, ie, FokI (rs10735810), BsmI (rs1544410), Cdx2 (rs11568820), ApaI (rs7976091), and TaqI (rs731236), and vitamin D binding protein gene polymorphisms GC1 (rs7041)/GC2 (rs4588) in a cross-sectional study. Mean ± standard deviation levels of 25-hydroxyvitamin D were 21.1 ± 9.0 ng/mL. Levels were deficient (<20 ng/mL) in 49% of patients. In contrast, 1,25-hydroxyvitamin D levels were considered normal in all patients. Higher circulating 25-hydroxyvitamin D levels were significantly associated with milder Parkinson's disease evaluated by Hoehn & Yahr stage (P = .002) and total Unified Parkinson's Disease Rating Stage (P = .004) even after multivariate adjustment for 8 covariates, including disease duration. However, significant associations were not observed in 1,25-hydroxyvitamin D levels. Under multivariate analysis with 25-hydroxyvitamin D as well as other 8 covariates including disease duration, carriers of vitamin D receptor FokICC genotype had a milder form of Parkinson's disease: odds ratio, 0.32; 95% confidence interval, 0.16 to 0.66, P = 0.002. These results suggest that higher 25-hydroxyvitamin D levels and the vitamin D receptor FokICC genotype may be independently associated with milder forms of Parkinson's disease. However, significant associations were not observed in 1,25-hydroxyvitamin D levels.</AbstractText>
<CopyrightInformation>Copyright © 2011 Movement Disorder Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Suzuki</LastName>
<ForeName>Masahiko</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Neurology, Jikei University School of Medicine, Tokyo, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yoshioka</LastName>
<ForeName>Masayuki</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hashimoto</LastName>
<ForeName>Masaya</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Murakami</LastName>
<ForeName>Maiko</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kawasaki</LastName>
<ForeName>Keiichi</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Noya</LastName>
<ForeName>Miki</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Takahashi</LastName>
<ForeName>Daisuke</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Urashima</LastName>
<ForeName>Mitsuyoshi</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2011</Year>
<Month>12</Month>
<Day>31</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018167">Receptors, Calcitriol</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>1406-16-2</RegistryNumber>
<NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>64719-49-9</RegistryNumber>
<NameOfSubstance UI="C104450">25-hydroxyvitamin D</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>66772-14-3</RegistryNumber>
<NameOfSubstance UI="C097949">1,25-dihydroxyvitamin D</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D015331">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D003430">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D020022">Genetic Predisposition to Disease</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D011110">Polymorphism, Genetic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D018167">Receptors, Calcitriol</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012720">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D014807">Vitamin D</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000031">analogs & derivatives</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year>
<Month>6</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2011</Year>
<Month>9</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2011</Year>
<Month>9</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="aheadofprint"><Year>2011</Year>
<Month>12</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2012</Year>
<Month>1</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2012</Year>
<Month>1</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2012</Year>
<Month>6</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.24016</ArticleId>
<ArticleId IdType="pubmed">22213340</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Japon</li>
</country>
<settlement><li>Tokyo</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Hashimoto, Masaya" sort="Hashimoto, Masaya" uniqKey="Hashimoto M" first="Masaya" last="Hashimoto">Masaya Hashimoto</name>
<name sortKey="Kawasaki, Keiichi" sort="Kawasaki, Keiichi" uniqKey="Kawasaki K" first="Keiichi" last="Kawasaki">Keiichi Kawasaki</name>
<name sortKey="Murakami, Maiko" sort="Murakami, Maiko" uniqKey="Murakami M" first="Maiko" last="Murakami">Maiko Murakami</name>
<name sortKey="Noya, Miki" sort="Noya, Miki" uniqKey="Noya M" first="Miki" last="Noya">Miki Noya</name>
<name sortKey="Takahashi, Daisuke" sort="Takahashi, Daisuke" uniqKey="Takahashi D" first="Daisuke" last="Takahashi">Daisuke Takahashi</name>
<name sortKey="Urashima, Mitsuyoshi" sort="Urashima, Mitsuyoshi" uniqKey="Urashima M" first="Mitsuyoshi" last="Urashima">Mitsuyoshi Urashima</name>
<name sortKey="Yoshioka, Masayuki" sort="Yoshioka, Masayuki" uniqKey="Yoshioka M" first="Masayuki" last="Yoshioka">Masayuki Yoshioka</name>
</noCountry>
<country name="Japon"><noRegion><name sortKey="Suzuki, Masahiko" sort="Suzuki, Masahiko" uniqKey="Suzuki M" first="Masahiko" last="Suzuki">Masahiko Suzuki</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F85 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000F85 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:22213340 |texte= 25-hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:22213340" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
This area was generated with Dilib version V0.6.23. |